Besides breast cancer, a putative relationship between MET and TGFBR2 expression was observed also in cell lines from other tumor entities using the NCI‐60 as well as the 789 cell line panels of the NCI and the Sanger Institute, respectively (Fig. S3B, C). The gene discussed is TGFBR2; the disease is neoplasm.